Indeed, platelet-derived TGF-β1 is reported to suppress the expression of natural killer (NK) group 2, member D (NKG2D), an activating surface receptor, on NK cells, resulting in reduced cytotoxicity in women with endometriosis [88]. Here, KLRK1 is linked to endometriosis.